Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Paradigm Biopharmaceuticals Ltd. has announced a change in the director’s securities holdings, with Paul Rennie disposing of 197,355 fully paid ordinary shares. Despite this reduction, Rennie continues to hold a significant number of shares across various accounts. This move could attract attention from investors watching director trading activities in the company.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.